Economic Atlas
Companies/Cumberland Pharmaceuticals Inc.
Company profile

Cumberland Pharmaceuticals Inc.

NASDAQ: CPIX · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Nashville, TN · DavidsonCIK 0001087294Reports USD
#449 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
70B
Revenue TTM
$41.9M
Rev growth YoY (TTM)
+2.1%
Net income (FY)
-$2.8M
Employees
88
as of 2026-09-15
Market cap
$100.4M
as of 2026-09-15

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$44.5M$44.5M2025
Net income-$2.8M-$2.8M2025
Operating income-$2.8M-$2.8M2025
Total assets$76.8M$76.8M2025
Liabilities$52.3M$52.3M2025
Equity$24.9M$24.9M2025

Revenue trend

FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product75%
Product - Vibativ18%
Product - Other8%
By geography
Non-US100%
The read

What is Cumberland Pharmaceuticals Inc.’s revenue?

Cumberland Pharmaceuticals Inc. booked $44.5M in FY2025 revenue, growing 437% year over year — faster than 94% of Healthcare companies we track, at a -6.4% net margin.

Peers · Healthcare
TriSalus Life Sciences, Inc.44DFennec Pharmaceuticals Inc.61CAquestive Therapeutics, Inc.47DNew York Health Care, Inc.——SANUWAVE Health Inc.74BHOOKIPA Pharma Inc.——
Neighbors
Davidson →
HCA Healthcare, Inc.$75.6B78B+Ryman Hospitality Properties, Inc.$2.6B65BHealthcare Realty Trust Incorporated$28.2M64CLouisiana-Pacific Corporation$2.7B73BAtmus Filtration Technologies Inc.$1.8B60CAllianceBernstein Holding L.P.——
Key facts
CEOA. J. Kazimi
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNashville, TN
ExchangeNASDAQ: CPIX
Employees88
IPO date2009-08-11
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.